- Home
- KELYA vs AQST Comparison
KELYA vs AQST Comparison
Compare KELYA & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KELYA
- AQST
- Stock Information
- Founded
- KELYA 1946
- AQST 2004
- Country
- KELYA United States
- AQST United States
- Employees
- KELYA N/A
- AQST N/A
- Industry
- KELYA Professional Services
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- KELYA Consumer Discretionary
- AQST Health Care
- Exchange
- KELYA Nasdaq
- AQST Nasdaq
- Market Cap
- KELYA 438.6M
- AQST 390.4M
- IPO Year
- KELYA N/A
- AQST 2018
- Fundamental
- Price
- KELYA $12.20
- AQST $3.96
- Analyst Decision
- KELYA Buy
- AQST Strong Buy
- Analyst Count
- KELYA 1
- AQST 7
- Target Price
- KELYA $25.00
- AQST $11.29
- AVG Volume (30 Days)
- KELYA 302.9K
- AQST 1.1M
- Earning Date
- KELYA 08-07-2025
- AQST 08-11-2025
- Dividend Yield
- KELYA 2.49%
- AQST N/A
- EPS Growth
- KELYA N/A
- AQST N/A
- EPS
- KELYA N/A
- AQST N/A
- Revenue
- KELYA $4,451,600,000.00
- AQST $54,228,000.00
- Revenue This Year
- KELYA $8.06
- AQST N/A
- Revenue Next Year
- KELYA $4.08
- AQST $51.62
- P/E Ratio
- KELYA N/A
- AQST N/A
- Revenue Growth
- KELYA N/A
- AQST 5.29
- 52 Week Low
- KELYA $10.80
- AQST $2.12
- 52 Week High
- KELYA $22.44
- AQST $5.80
- Technical
- Relative Strength Index (RSI)
- KELYA 44.88
- AQST 50.64
- Support Level
- KELYA $11.89
- AQST $3.73
- Resistance Level
- KELYA $13.52
- AQST $4.10
- Average True Range (ATR)
- KELYA 0.42
- AQST 0.22
- MACD
- KELYA -0.13
- AQST -0.07
- Stochastic Oscillator
- KELYA 17.51
- AQST 17.42
About KELYA Kelly Services Inc.
Kelly Services Inc is a provider of workforce solutions and consulting, and staffing services. The company's operations are divided into four business segments, namely Professional & Industrial, Science, Education, Outsourcing & Consulting Group, and International. Other than OCG, each segment delivers talent through staffing services, permanent placement, or outcome-based services. OCG segment delivers talent solutions, including managed service providers, payroll process outsourcing, recruitment process outsourcing, and talent advisory services. International also delivers RPO talent solutions within its local markets. The majority of revenue is derived from Professional & Industrial.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.